Combined Administration of Fibrinogen and Factor XIII Concentrate Does Not Improve Dilutional Coagulopathy Superiorly Than Sole Fibrinogen Therapy: Results of an In-Vitro Thrombelastographic Study

The early administration of fibrinogen has gained wide acceptance for the treatment of major hemorrhage, whereas the substitution of coagulation factor XIII (FXIII) is only supported by a low level of evidence. This study aimed to answer the question of whether a combined therapy of fibrinogen/FXIII...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneck, Emmanuel, Muelich, Marcus, Markmann, Melanie, Edinger, Fabian, Cooper, Nina, Moeller, Annette, Bein, Gregor, Hecker, Andreas, Koch, Christian, Sander, Michael, Wolff, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150940/
https://www.ncbi.nlm.nih.gov/pubmed/34065924
http://dx.doi.org/10.3390/jcm10102068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150940/
https://www.ncbi.nlm.nih.gov/pubmed/34065924
http://dx.doi.org/10.3390/jcm10102068

Ejemplares similares